The journey of a medical device does not end after regulatory approval and market launch. Manufacturers must continuously monitor the safety, performance, and clinical benefits of their products throughout their lifecycle. This ongoing responsibility is fulfilled through a robust post-market surveillance system, with one of its most important outputs being the PSUR medical devices document.
A well-prepared periodic safety update report enables manufacturers to demonstrate that their devices continue to meet regulatory requirements while protecting patients and healthcare professionals. It provides a comprehensive overview of safety data, clinical evidence, risk assessments, and post-market findings gathered over a specific reporting period.
This article explores the importance of PSURs, their regulatory requirements, essential components, and best practices for creating compliant reports.
What Are PSUR Medical Devices?
PSUR medical devices refers to the Periodic Safety Update Report required under the European Union Medical Device Regulation (EU MDR 2017/745). It is a structured document that summarises the results of post-market surveillance activities and evaluates whether a medical device continues to perform safely and effectively.
Unlike pre-market clinical evidence, a PSUR focuses on real-world experience after the device has been commercialised. Manufacturers collect data from hospitals, healthcare professionals, distributors, patients, complaint records, scientific publications, and clinical studies to identify any emerging safety concerns.
The ultimate goal is to confirm that the device's clinical benefits continue to outweigh any associated risks.
What Is a Periodic Safety Update Report?
A periodic safety update report is a regulatory document that provides an organised review of all relevant safety and performance information collected during a defined reporting period.
Rather than listing complaints or incidents individually, the report analyses trends, evaluates risks, and determines whether corrective actions are necessary.
A typical PSUR includes:
- Device identification and description
- Post-market surveillance summary
- Sales and distribution data
- Estimated patient exposure
- Complaint analysis
- Serious incident reviews
- Trend reporting
- Benefit-risk evaluation
- Corrective and preventive actions
- Conclusions and recommendations
This comprehensive approach helps regulators assess whether the device remains compliant with applicable safety requirements.
Why Is a PSUR Important?
Preparing a high-quality PSUR benefits both manufacturers and patients.
Protects Patient Safety
Continuous monitoring helps identify potential risks before they develop into widespread safety issues.
Supports Regulatory Compliance
The EU MDR requires manufacturers of many medical devices to prepare and maintain PSURs throughout the product lifecycle.
Improves Product Quality
Real-world user feedback often identifies opportunities for improving design, labelling, usability, or manufacturing processes.
Strengthens Risk Management
New findings collected through post-market surveillance allow manufacturers to update their risk management documentation and maintain an accurate benefit-risk profile.
Demonstrates Manufacturer Responsibility
A well-documented PSUR shows regulatory authorities that the manufacturer actively monitors product performance and takes appropriate corrective action when necessary.
Who Needs to Prepare a PSUR?
The reporting requirements depend on the medical device classification.
Class III Devices
Manufacturers must prepare and update the PSUR annually.
Class IIb Devices
Annual updates are generally required unless otherwise specified by regulatory authorities.
Class IIa Devices
Manufacturers should update the report at least every two years.
Class I Devices
Although a PSUR is generally not mandatory, manufacturers must still maintain appropriate post-market surveillance documentation.
Key Elements of a High-Quality PSUR
An effective PSUR combines information from multiple sources into a clear regulatory document.
Device Information
Include:
- Device name
- Intended purpose
- Risk classification
- UDI details
- Product variants
Providing accurate identification ensures traceability throughout the reporting process.
Post-Market Surveillance Activities
Summarise surveillance activities such as:
- Complaint handling
- Customer feedback
- Literature reviews
- Clinical evaluations
- PMCF studies
- Distributor reports
This section demonstrates that surveillance activities have been performed systematically.
Sales and Population Data
Manufacturers estimate:
- Number of units sold
- Countries where devices are marketed
- Estimated number of patients treated
This information provides context when analysing incident frequencies.
Complaint Evaluation
Review all reported complaints to identify recurring issues, root causes, and trends.
Manufacturers should explain whether complaints indicate isolated events or broader product concerns.
Serious Incident Assessment
The report should summarise:
- Reportable incidents
- Field Safety Corrective Actions (FSCAs)
- Product recalls
- Safety notices
Any corrective actions implemented should be clearly documented.
Clinical Evidence Review
Clinical literature, published studies, and Post-Market Clinical Follow-up (PMCF) data provide valuable evidence supporting continued device safety and effectiveness.
Benefit-Risk Analysis
One of the most important sections evaluates whether the clinical benefits continue to outweigh known and newly identified risks.
Relationship Between PSUR and Post-Market Surveillance
The PSUR is an important output of the manufacturer's overall Post-Market Surveillance (PMS) system.
A comprehensive PMS programme includes:
- Complaint management
- Vigilance reporting
- Trend analysis
- PMCF activities
- Customer feedback
- Risk management updates
- CAPA implementation
- Regulatory reporting
The PSUR consolidates all of this information into one structured regulatory document.
Common Challenges When Preparing a PSUR
Many manufacturers encounter obstacles during report preparation.
Collecting Reliable Data
Information is often spread across multiple departments, making data consolidation challenging.
Maintaining Documentation Consistency
Risk management files, technical documentation, clinical evaluations, and PSURs must all remain aligned.
Identifying Safety Trends
Small increases in complaint rates may indicate emerging risks that require detailed investigation.
Keeping Up With Regulations
Manufacturers must remain informed about evolving MDR guidance and notified body expectations.
Best Practices for Preparing a Compliant PSUR
Developing a high-quality report becomes easier by following proven best practices.
Maintain Continuous Surveillance
Collect data throughout the year instead of waiting until reporting deadlines.
Standardise Data Collection
Use consistent procedures across complaints, vigilance reports, and clinical feedback.
Integrate Risk Management
Update risk analyses whenever new hazards or trends are identified.
Conduct Internal Reviews
Quality assurance and regulatory teams should verify the report before submission.
Keep Clinical Evidence Current
Regular literature reviews and PMCF activities ensure benefit-risk evaluations remain accurate.
Benefits of Expert Regulatory Support
Preparing PSURs requires expertise in regulatory affairs, clinical evaluation, quality management, and post-market surveillance.
Professional consultants can assist with:
- PSUR preparation
- PMS planning
- Clinical data analysis
- Risk management updates
- Technical documentation
- PMCF reports
- EU MDR compliance
- Notified Body submissions
Their expertise helps manufacturers reduce compliance risks while improving documentation quality.
Conclusion
The PSUR medical devices process plays a vital role in ensuring that medical devices remain safe, effective, and compliant after entering the market. A comprehensive periodic safety update report allows manufacturers to evaluate real-world performance, analyse safety trends, update benefit-risk assessments, and demonstrate ongoing compliance with EU MDR requirements.
By establishing a strong post-market surveillance system and preparing accurate, well-structured PSURs, manufacturers can protect patients, satisfy regulatory authorities, and strengthen confidence in their medical devices. Continuous monitoring, timely reporting, and proactive risk management are essential for achieving long-term regulatory success and maintaining a competitive position in the global healthcare industry.